Alexis Kidd received her mesothelioma diagnosis more than 12 years ago. So excuse her for not remembering everything about the months leading up to it, or the months following. She does remember one detail: Her doctor was “angry.” “He was angry that I could not explain to him how I ended up...
Read More
Keytruda, the brand name for pembrolizumab, has been a source of hope for many people with mesothelioma. At a recent medical conference, researchers revealed discouraging news...
Read PostThere are two primary surgeries for pleural mesothelioma patients: extrapleural pneumonectomy and pleurectomy with decortication. Some mesothelioma experts suggest a third: talc...
Read PostMesothelioma Guide’s newest podcast features the lead investigator into a promising Phase 3 mesothelioma clinical trial. Dr. Daniel Sterman is the director of the...
Read Post
On May 23, 2019, a press release from the company Novocure made history. It announced that the United States Food and Drug Administration (FDA) had approved the NovoTTF-100L...
Read Post
Imagine it’s seven years from now. Or maybe it’s 10 or 20 years into the future. A person is told difficult-to-hear news from their doctor: They have mesothelioma, a rare and...
Read Post
Immunotherapy drugs are commonplace in mesothelioma clinical trials. However, in many cases, these drugs can’t fight cancer alone. A new Phase 2 pleural mesothelioma clinical...
Read Post
You’re a mesothelioma patient. You just received your diagnosis. Now you’re trying to understand the disease you have. How much do you know about it? Can you recite the names...
Read Post
May 23, 2019, is one of the most noteworthy dates in the history of mesothelioma. On that date, the U.S. Food and Drug Administration (FDA) approved a new treatment for pleural...
Read Post
The Phase 3 clinical trial for pleural mesothelioma is now looking for participants. The study is testing the effectiveness of gene therapy, immunotherapy and virotherapy...
Read Post
No two patients have the exact same mesothelioma. That’s an often-used line when specialists talk about treating the disease. If each person’s mesothelioma is unique, then...
Read Post
